These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24656112)

  • 1. Comorbidities and polypharmacy.
    von Lueder TG; Atar D
    Heart Fail Clin; 2014 Apr; 10(2):367-72. PubMed ID: 24656112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy in heart failure: drugs to use and avoid.
    Reed BN; Rodgers JE; Sueta CA
    Heart Fail Clin; 2014 Oct; 10(4):577-90. PubMed ID: 25217433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-related problems in the elderly].
    Bor A; Matuz M; Doró P; Viola R; Soós G
    Orv Hetil; 2012 Dec; 153(49):1926-36. PubMed ID: 23204299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polypharmacy and drug interactions in elderly patients].
    Yıldırım AB; Kılınç AY
    Turk Kardiyol Dern Ars; 2017 Sep; 45(Suppl 5):17-21. PubMed ID: 28976374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific differences in non-cardiac comorbidities among elderly patients hospitalized with heart failure: a special focus on young-old, old-old, and oldest-old.
    Yang MX; An H; Fan XQ; Tao LY; Tu Q; Qin L; Zhang LF; Feng DP; Wang Y; Sun L; Gao S; Guan WZ; Zheng JG; Ren JY
    Chin Med J (Engl); 2019 Dec; 132(24):2905-2913. PubMed ID: 31809320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study.
    Ahmed B; Nanji K; Mujeeb R; Patel MJ
    PLoS One; 2014; 9(11):e112133. PubMed ID: 25402452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy in heart failure patients.
    Mastromarino V; Casenghi M; Testa M; Gabriele E; Coluccia R; Rubattu S; Volpe M
    Curr Heart Fail Rep; 2014 Jun; 11(2):212-9. PubMed ID: 24493574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions.
    Ledwidge M; Travers B; Ryder M; Ryan E; McDonald K
    Eur J Heart Fail; 2004 Mar; 6(2):235-43. PubMed ID: 14984732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy in older adults at home: what it is and what to do about it-implications for home healthcare and hospice, part 2.
    Riker GI; Setter SM
    Home Healthc Nurse; 2013 Feb; 31(2):65-77; quiz 78-9. PubMed ID: 23385171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing comorbidities in patients with chronic heart failure: first, do no harm.
    DeJongh B; Birkeland K; Brenner M
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):171-84. PubMed ID: 25837622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological rationale behind polypharmacy in heart failure.
    Kappert K; Kusserow H; Unger T
    Heart Fail Monit; 2008; 6(1):20-7. PubMed ID: 18607518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequent drug interactions in old age].
    Wagner CC; Locher P; Elke B; Corti N
    Praxis (Bern 1994); 2009 Oct; 98(21):1185-90; quiz 1191-2. PubMed ID: 19844875
    [No Abstract]   [Full Text] [Related]  

  • 15. Medication errors in the older people population.
    Mira JJ
    Expert Rev Clin Pharmacol; 2019 Jun; 12(6):491-494. PubMed ID: 31063401
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic.
    Gastelurrutia P; Benrimoj SI; Espejo J; Tuneu L; Mangues MA; Bayes-Genis A
    J Card Fail; 2011 Mar; 17(3):217-23. PubMed ID: 21362530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy, aging, and cancer.
    Tam-McDevitt J
    Oncology (Williston Park); 2008 Aug; 22(9):1052-5, discussion 1055, 1058, 1060. PubMed ID: 18777955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from our elders: how to study polypharmacy in populations with intellectual and developmental disabilities.
    Stortz JN; Lake JK; Cobigo V; Ouellette-Kuntz HM; Lunsky Y
    Intellect Dev Disabil; 2014 Feb; 52(1):60-77. PubMed ID: 24635692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of heart failure in the elderly: adverse events.
    Rich MW
    Heart Fail Rev; 2012 Sep; 17(4-5):589-95. PubMed ID: 21688185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure in the elderly: advances and challenges.
    Jugdutt BI
    Expert Rev Cardiovasc Ther; 2010 May; 8(5):695-715. PubMed ID: 20450303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.